Monthly revenue and year-on-year change for GeneReach Biotechnology (4171) and DaBomb Protein Biotech (6578) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.
Year-on-year change
Monthly revenue history
| Month | GeneReach Biotechnology | YoY | DaBomb Protein Biotech | YoY |
|---|---|---|---|---|
| Oct 2026 | NT$21.7 million | +12.3% | NT$40.1 million | +45.4% |
| Sep 2026 | NT$15 million | -20.0% | NT$34.6 million | +29.7% |
| Aug 2026 | NT$18.2 million | +6.2% | NT$34 million | +97.4% |
| Jul 2026 | NT$23.3 million | +32.9% | NT$37.7 million | +50.4% |
| Jun 2026 | NT$22 million | +27.3% | NT$35.2 million | +35.8% |
| May 2026 | NT$17.8 million | -0.6% | NT$35.9 million | +27.2% |
| Apr 2026 | NT$20.2 million | +4.7% | NT$36.4 million | -1.0% |
| Mar 2026 | NT$21.6 million | +15.8% | NT$34 million | +24.0% |
| Feb 2026 | NT$13.6 million | -44.7% | NT$22.3 million | +40.0% |
| Jan 2026 | NT$17.1 million | +84.9% | NT$25.8 million | +2.1% |
| Dec 2025 | NT$30.4 million | +56.0% | NT$28.9 million | +74.7% |
| Nov 2025 | NT$22.6 million | +11.9% | NT$24.5 million | -30.2% |
| Oct 2025 | NT$19.3 million | +26.8% | NT$27.6 million | -8.4% |
← All Taiwan listed & OTC companies
Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16